SAN DIEGO, May 19, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of shares of Inari Medical, Inc. (NASDAQ:NARI) common stock between February 24, 2022 and February 28, 2024, both dates inclusive (the "Class Period"), have until May 13, 2024 to seek appointment as lead plaintiff of the Inari Medical class action lawsuit. Captioned Michiana Area Electrical Workers' Pension Fund v. Inari Medical, Inc., No. 24-cv-03686 (S.D.N.Y.), the Inari Medical class action lawsuit charges Inari Medical and certain of Inari Medical's top current and former executives with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Inari Medical class action lawsuit, please provide your information here:
https://www.rgrdlaw.com/cases-inari-medical-inc-class-action-lawsuit-nari.html
You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com. Lead plaintiff motions for the Inari Medical class action lawsuit must be filed with the court no later than May 13, 2014.
CASE ALLEGATIONS: Inari Medical is a medical device company that specializes in developing, manufacturing, and commercializing ...